A

SELL

Agilent Technologies, Inc.

Healthcare · Rank #161 · Analyzed Apr 20, 2026

$121.87

Current Price

$58.84

Intrinsic Value

-29.9%

Upside/Downside

3.5/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score3.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 29.9%

Fair Value Range

Low$19.08

Base (IV)$58.84

High$85.43

Entry Points

Conservative$19.08

Moderate$38.96

Aggressive$58.84

Quality & Moat Breakdown

Return on Equity19.9% → 1.0/1.0

Debt LevelD/E 51 → 0.5/1.0

Revenue QualityGrowth 11.1%, margin Δ-8.6% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins18.3% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.